Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
about
Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial designMobile Phone Text Messages to Support Treatment Adherence in Adults With High Blood Pressure (SMS-Text Adherence Support [StAR]): A Single-Blind, Randomized Trial.Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.Controlled multi-arm platform design using predictive probability.Housing First Improves Adherence to Antipsychotic Medication Among Formerly Homeless Adults With Schizophrenia: Results of a Randomized Controlled Trial.Statistical reporting in randomized controlled trials from the dermatology literature: a review of 44 dermatology journals.Many-to-one comparisons after safety selection in multi-arm clinical trials.Continuously updated network meta-analysis and statistical monitoring for timely decision-making.Recommendations on multiple testing adjustment in multi-arm trials with a shared control group.An introduction to multiplicity issues in clinical trials: the what, why, when and how.A Bayesian adaptive design for biomarker trials with linked treatments.Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes.Effectiveness of two web-based cognitive bias modification interventions targeting approach and attentional bias in gambling problems: study protocol for a pilot randomised controlled trial.Adding experimental arms to platform clinical trials: randomization procedures and interim analyses.Arthroscopic subacromial decompression for subacromial shoulder pain (CSAW): a multicentre, pragmatic, parallel group, placebo-controlled, three-group, randomised surgical trial.Two-by-Two Factorial Cancer Treatment Trials: Is Sufficient Attention Being Paid to Possible Interactions?Participation restrictions among adolescents and adults with neonatal brachial plexus palsy: the patient perspective.Adaptive designs in clinical trials: why use them, and how to run and report them.Feasibility of a clinical trial to assess the effect of dietary calcium v. supplemental calcium on vascular and bone markers in healthy postmenopausal women.P values in display items are ubiquitous and almost invariably significant: A survey of top science journals.Protocol of the randomised placebo controlled pilot trial of the management of acute sciatica (SCIATICA): a feasibility study.Group sequential crossover trial designs with strong control of the familywise error rate
P2860
Q36078353-34B94F8D-36D5-44A5-8C6B-35D479520D83Q36570501-8BF50C93-AA3B-4695-83E0-D261227A2577Q36707077-1CC95978-D19E-4EBE-8C0C-8EDA4B22F931Q37289826-F3E3202E-119E-4376-B99A-72CD0917BD08Q37611162-0A0BBBBA-A0F4-4AB6-BFC5-0EE30A18FDBAQ38491401-6091CF88-D43F-442E-A80F-DDFBF1E623EDQ38708697-56DB7340-D291-4524-98AF-BD87B1D860D4Q38825084-C78BC30A-5D0B-4BE6-8899-4312A822C379Q39372233-1BCEC5AA-0626-48D7-A991-330EBF351666Q40406803-A244E44B-9EFE-411B-9BA3-6CA1AA304136Q41835806-F19B872C-F117-47FC-B871-C4ACE78893EEQ41857207-EC2100E1-C122-4F0E-9A43-F3F41A6D7887Q42172270-712AAF26-BFC7-421D-8C99-62FD73BC5894Q45304949-5F9571EE-41B2-4F7F-ABE1-6883A8EFE55EQ47208067-4C962B77-F993-4978-95F4-3552D7F28A12Q47258794-DF137465-738A-4CCA-B0C8-F7F4B54FEB41Q47680345-B9EC1990-2532-4055-8150-86F0B2664C55Q52681001-83DC1873-5FE0-493E-95D7-8358946F2921Q53099035-BC3402FE-D304-48C6-85AB-6B06ADA8F65FQ55186690-C2E946B1-8F0E-476B-837C-7BF7970E73B3Q55646000-F55BE9F1-DF5B-474E-A4A1-46011C5F9DC9Q58587422-5AE862E3-D0BC-4C63-9E62-17C8FCEDDF74
P2860
Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
@en
type
label
Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
@en
prefLabel
Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
@en
P2860
P356
P1433
P1476
Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
@en
P2093
Adrian P Mander
Lynne Stecher
P2860
P2888
P356
10.1186/1745-6215-15-364
P50
P577
2014-09-17T00:00:00Z
P5875
P6179
1048568123